Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.82 |
| ▸ | GUSB | P08236 | 1/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.79 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.79 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.72 |
| ▸ | HPGD | P15428 | 1/20 | 0.72 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
| ▸ | NPC1 | O15118 | 1/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | NPY1R | P25929 | 1/20 | 0.64 |
| ▸ | NPY2R | P49146 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 3/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25481992 | 0.89 | SMN1; SMN2 (0.77) | LMNAGUSBALDH1A1L3MBTL1SMN1; SMN2 | |
| SCHEMBL30774061 | 0.80 | L3MBTL1 (0.75) | LMNAGUSBALDH1A1L3MBTL1HPGD | |
| SCHEMBL1895578 | 0.80 | L3MBTL1 (0.75) | LMNAGUSBALDH1A1L3MBTL1HPGD | |
| SCHEMBL25481997 | 0.79 | TSHR (0.71) | LMNAGUSBALDH1A1L3MBTL1SMN1; SMN2 | |
| SCHEMBL15986415 | 0.78 | TSHR (1.00) | LMNAALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL25482008 | 0.75 | L3MBTL1 (0.78) | LMNAGUSBALDH1A1L3MBTL1MEN1 | |
| SCHEMBL15986587 | 0.74 | MAPT (1.00) | LMNAALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL18559082 | 0.74 | TSHR (1.00) | LMNAALDH1A1L3MBTL1SMN1; SMN2MEN1 | |
| SCHEMBL25482060 | 0.74 | KMT2A (0.74) | LMNAALDH1A1L3MBTL1SMN1; SMN2HPGD | |
| SCHEMBL25482064 | 0.73 | LMNA (0.69) | LMNAALDH1A1SMN1; SMN2HPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230158028-A1 | COMPOUNDS AND METHODS FOR INDUCING UCP1 EXPRESSION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-05-25 | — | — | US | disclosed |
| US-20230158028-A1 | COMPOUNDS AND METHODS FOR INDUCING UCP1 EXPRESSION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230158028-A1 | COMPOUNDS AND METHODS FOR INDUCING UCP1 EXPRESSION | TFAM, FABP4, CPT2 | LMNA 688/4885GUSB 3022/4885ALDH1A1 1604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.